Mnb Rlp2086 Subfamily A Protein
Generic Name: mnb rlp2086 subfamily a protein
Dosage form: SUSPENSION. Active ingredients: NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN (.06 mg/.06mg). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: SUSPENSION. Active ingredients: NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN (.06 mg/.06mg). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as suspension.
Related Medications
Dextromethorphan Hydrobromide, Guaifenesin, Doxylamine Succinate
dextromethorphan hydrobromide, guaifenesin, doxylamine succinate
Purposes – Robitussin Maximum Strength Cough+Chest Congestion DM Cough suppressant Expectorant
Valsartan
valsartan
Angiotensin 2 Receptor Blocker [EPC]
11 DESCRIPTION Valsartan is a nonpeptide, orally active, and specific angiotensin II receptor blocker acting on the AT 1 receptor subtype. Valsartan is chemically described as L-valine, N -(1-oxopentyl)- N -[[2′-(1 H -tetrazol-5-yl) [1,1′-biphenyl]-4-yl]methyl]-. Its molecular formula is C 24 H 29 N 5 O 3 , its molecular weight is 435.52, and its structural formula is Valsartan, USP is a white to an off-white powder. It is soluble in ethanol and methanol and insoluble in water.
Avobenzone, Humosalate, Octisalate, Octocrylene
avobenzone, humosalate, octisalate, octocrylene
Avobenzone 3.0% ……………………………………………………………………………… Sunscreen Homosalate 15.0% ……………………………………………………………………………. Sunscreen Octisalate 5.0% …………………………………………………………………………………. Sunscreen Octocrylene 10.0% ……………………………………………………………………………. Sunscreen
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.